Significant Tumor Reduction With Traditional Chinese Medicine in a Patient With Advanced Prostate Cancer: A Case Report

Prostate cancer (PC) is the most common malignancy of the male genitourinary system. For patients with advanced progressive PC, the treatment strategies include second-line endocrine therapy, chemotherapy, and immunotherapy. Such therapeutic techniques are either too expensive or too toxic for some...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of men's health Vol. 16; no. 5; p. 15579883221130854
Main Author Zhang, Xiaojun
Format Journal Article
LanguageEnglish
Published Los Angeles, CA SAGE Publications 01.09.2022
SAGE PUBLICATIONS, INC
SAGE Publishing
Subjects
Aged
Case reports
Chemotherapy
Chinese medicine
Endocrine therapy
Hemodialysis
Heparin, Low-Molecular-Weight
Humans
Male
Medicine, Chinese Traditional
Prostate cancer
Prostatic Neoplasms - drug therapy
Urological Cancer
Shi-pi-san
case report
traditional Chinese medicine
prostate cancer
Gui-zhi-Fu-ling-wan
Online AccessGet full text

Cover

More Information
Summary:Prostate cancer (PC) is the most common malignancy of the male genitourinary system. For patients with advanced progressive PC, the treatment strategies include second-line endocrine therapy, chemotherapy, and immunotherapy. Such therapeutic techniques are either too expensive or too toxic for some patients, and traditional Chinese medicine (TCM) has become an alternative for its low cost and low toxicity. The application of Shi-pi-san and Gui-zhi-Fu-ling-wan in PC has never been reported. We report their application on a 71-year-old male patient, who was diagnosed with PC and was undergoing endocrine therapy. He originally chose chemotherapy, and experienced acute renal failure, which required hemodialysis during hospitalization. He felt weak and opted for Chinese herbal medicine treatment. After treatment with Shi-pi-san and Gui-zhi-Fu-ling-wan, the patient’s tumor and other symptoms were significantly reduced, and he reported feeling “refreshed.” This case indicates that TCM treatment has unique advantages and is more tolerable than endocrine therapy and chemotherapy. Considering that the patient was undergoing hemodialysis treatment and using low-molecular-weight heparin (LMWH) to prevent blood coagulation while taking TCM, whether LMWH has a synergistic anticancer effect remains to be explored.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:1557-9883
1557-9891
1557-9891
DOI:10.1177/15579883221130854